media

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Alembic Pharmaceuticals Ltd.
( in Crs.)

ParticularsMar 24Mar 23Mar 22Mar 21Mar 20
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue2.002.002.002.002.00
      
      
INCOME     
Revenue From Operations [Net]6228.635499.775231.795276.224491.97
Other Operating Revenues0.00152.8574.00116.91113.78
Total Operating Revenues6228.635652.625305.795393.134605.75
      
Other Income28.312.7450.4610.024.94
Total Revenue6256.945655.365356.255403.154610.69
      
EXPENSES     
Cost Of Materials Consumed1403.011250.081129.111185.35979.05
Purchase Of Stock-In Trade454.91380.09360.50265.92270.93
Operating And Direct Expenses0.0050.900.0022.3917.56
Changes In Inventories Of FG,WIP And Stock-In Trade-142.8478.65-43.19-193.93-210.59
Employee Benefit Expenses1446.291169.131133.001051.17906.44
Finance Costs56.1950.1717.7316.0227.16
Depreciation And Amortisation Expenses272.67275.43286.78183.47157.32
Other Expenses2133.912015.391852.211504.681419.34
Total Expenses5624.145269.844736.144035.073567.21
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax632.80385.52620.111368.081043.48
      
Exceptional Items0.000.000.000.00-43.65
Profit/Loss Before Tax632.80385.52620.111368.08999.83
      
Tax Expenses-Continued Operations     
Current Tax16.004.20129.18255.47204.57
Deferred Tax0.009.20-23.47-9.56-4.30
Tax For Earlier Years0.00-0.79-1.257.41-1.09
Total Tax Expenses16.0012.61104.46253.32199.18
Profit/Loss After Tax And Before ExtraOrdinary Items616.80372.91515.651114.76800.65
      
Profit/Loss From Continuing Operations616.80372.91515.651114.76800.65
      
Profit/Loss For The Period616.80372.91515.651114.76800.65
      
Minority Interest0.000.000.0031.6128.12
Share Of Profit/Loss Of Associates-0.98-30.925.2931.740.05
Consolidated Profit/Loss After MI And Associates615.82341.99520.941178.11828.82
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)31.3317.4026.5060.8143.97
Diluted EPS (Rs.)31.3317.4026.5060.8143.97
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend0.00196.56275.190.00325.97
ParticularsMar 24
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue2.00
  
INCOME 
Revenue From Operations [Net]6228.63
Other Operating Revenues0.00
Total Operating Revenues6228.63
Other Income28.31
Total Revenue6256.94
EXPENSES 
Cost Of Materials Consumed1403.01
Purchase Of Stock-In Trade454.91
Operating And Direct Expenses0.00
Changes In Inventories Of FG,WIP And Stock-In Trade-142.84
Employee Benefit Expenses1446.29
Finance Costs56.19
Depreciation And Amortisation Expenses272.67
Other Expenses2133.91
Total Expenses5624.14
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax632.80
Exceptional Items0.00
Profit/Loss Before Tax632.80
Tax Expenses-Continued Operations 
Current Tax16.00
Deferred Tax0.00
Tax For Earlier Years0.00
Total Tax Expenses16.00
Profit/Loss After Tax And Before ExtraOrdinary Items616.80
Profit/Loss From Continuing Operations616.80
Profit/Loss For The Period616.80
Minority Interest0.00
Share Of Profit/Loss Of Associates-0.98
Consolidated Profit/Loss After MI And Associates615.82
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)31.33
Diluted EPS (Rs.)31.33
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend0.00